- Report
- January 2023
- 165 Pages
Global
From €2195EUR$2,500USD£1,918GBP
- Report
- February 2024
- 104 Pages
Europe
From €2590EUR$2,950USD£2,264GBP
- Report
- November 2023
- 101 Pages
Asia Pacific
From €1076EUR$1,225USD£940GBP
€2151EUR$2,450USD£1,880GBP
- Report
- July 2023
- 146 Pages
Global
From €2930EUR$3,338USD£2,561GBP
€3907EUR$4,450USD£3,414GBP
- Book
- March 2021
- 400 Pages
From €145EUR$165USD£127GBP
- Report
- October 2025
- 23 Pages
United States
- Report
- October 2025
- 8 Pages
United States
- Report
- October 2025
United States
- Report
- October 2025
- 21 Pages
Germany
- Report
- December 2025
- 8 Pages
United States
- Report
- November 2025
- 8 Pages
New Zealand
- Report
- November 2025
- 8 Pages
China
- Report
- November 2025
- 8 Pages
Australia
- Report
- November 2025
- 8 Pages
Argentina
- Report
- November 2025
- 8 Pages
Global
- Report
- November 2025
- 8 Pages
Poland
- Report
- November 2025
- 8 Pages
Poland
- Report
- November 2025
- 8 Pages
Denmark
- Report
- November 2025
- 8 Pages
Denmark
- Report
- November 2025
- 8 Pages
Denmark

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more